Subsequent myocardial infarction

Overview

Diagnosis

Management

Special Populations

Key Recommendations

References

Showing 100 most recent of 590 indexed papers.

1 Borges do Nascimento IJ, Lopes RD, Malveira De Lima MV, Itaborahy MF, Fanaroff AC, Sathian B et al.. Coevolutionary analysis of evidence and recommendations in STEMI clinical practice guidelines: A 33-year meta-research study of ACC, AHA, and ESC. American heart journal 2026. link 2 Mattia E, Paoletti F, Pedicino D, Angioletti C, Perilli A, d'Aiello A et al.. Advantages and challenges of tracking st-segment elevation myocardial infarction patients with a real-time dashboard: A single-centre experience. International journal of medical informatics 2026. link 3 Yang J, Xu D, Liu X, Zhao Z, Zhang J. The triglyceride-glucose index and neutrophil-to-lymphocyte ratio jointly predict the no-reflow phenomenon in T2DM patients with STEMI after primary PCI. PloS one 2026. link 4 Lu Z, Zang T, Li H, Liu Y, Shen L, Huang L. Persistent Sex Disparities in Pre-Hospital Delay Among Patients With STEMI Despite Overall Improvements: Findings From the Chinese Cardiovascular Association Chest Pain Center Registry. Journal of the American Heart Association 2026. link 5 Chaturonrutsamee P, Lertlaksameewilai P, Numkiatsakul N. Impact of aspiration catheter size on thrombus removal and slow-flow/no-reflow in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coronary artery disease 2026. link 6 Pereira H, Pereira AR, Calé R, Orlić D, Delport R, Abdi S et al.. Worldwide procedural variations of primary percutaneous coronary intervention for ST-elevation myocardial infarction: Insights from the "Stent - Save a Life!" initiative. Cardiovascular revascularization medicine : including molecular interventions 2026. link 7 Rafizadeh O, Erfani S, Zarbafti S, Erfani S. The effects of delays at each stage of care on mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coronary artery disease 2026. link 8 Sritharan HP, Nguyen H, Ciofani JL, Bhindi R, Allahwala UK. Development and validation of a machine learning model for prediction of 1-year mortality following ST-elevation myocardial infarction: a retrospective cohort study. BMJ open 2026. link 9 Kumar R, Shaikh AH, Mir A, Safdar U, Fatima I, Batra MK et al.. Prognosticating short-term outcomes in patients with STEMI-ACS and intra-procedural slow-flow/no-reflow phenomenon. Herz 2026. link 10 Lima TCRM, Cunha Oliveira J, Cunha-Oliveira J, de Carvalho Barreto ID, Almeida-Santos MA, Oliveira LCS et al.. Disparities in access and three-year survival of patients with ST-elevation myocardial infarction treated in percutaneous coronary intervention-capable hospitals within the Brazilian public and private healthcare systems: The VICTIM extended registry. Public health 2026. link 11 Franchin L, Angriman F, Pezzato A, Vignut LS, Fabris E, Sinagra G et al.. Heparin pretreatment in patients with ST-segment elevation myocardial infarction: A meta-analysis. Cardiovascular revascularization medicine : including molecular interventions 2026. link 12 Laffan J, Gao H, Street A, Coughlan JJ, Armstrong R, Maree A et al.. Outcomes according to timely or delayed primary percutaneous coronary intervention or fibrinolysis in a national registry of patients with ST-segment elevation myocardial infarction. Open heart 2026. link 13 Karakurt H, Karakurt ST. The Prognostic Significance of the Novel Global Immune-Nutrition-Inflammation Index in Forecasting In-Hospital Mortality in Patients With ST-Elevation Myocardial Infarction. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026. link 14 Goyal A, Maheshwari S, Shahbaz H, Shah V, Shamim U, Shrestha AB et al.. The Presence of Chronic Total Occlusion in Noninfarct-Related Arteries Is Associated With Higher Mortality and Worse Patient Outcomes Following Percutaneous Coronary Intervention for STEMI: A Systematic Review, Meta-Analysis and Meta-Regression. Cardiology in review 2026. link 15 Zhao H, Tao Z, Wang X, Li X, Chang H, Ji DK et al.. Fasting stress hyperglycemia ratio as a predictor of intramyocardial hemorrhage and adverse outcomes in ST-segment elevation myocardial infarction. Frontiers in endocrinology 2026. link 16 Kasahara T, Sakakura K, Jinnouchi H, Taniguchi Y, Yamamoto K, Tsukui T et al.. Impact of visually identified in-stent protrusion on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction. Cardiovascular intervention and therapeutics 2026. link 17 Ahn JH, Park S, Lee SH, Oh S, Lim Y, Hyun DY et al.. Evaluating the Efficacy of AI-Assisted Quantitative Coronary Angiography in Reducing Procedural Time for Primary PCI in STEMI Patients: A Retrospective Analysis. Journal of Korean medical science 2026. link 18 Khalaph M, Trajkovska N, Didenko M, Sohns C, Imnadze G, El Hamriti M et al.. Purkinje and septal substrate modification as a therapeutic option for patients with STEMI and refractory ventricular fibrillation. Heart rhythm 2026. link 19 Herman R, Mumma BE, Hoyne JD, Cooper BL, Johnson NP, Kisova T et al.. AI-Enabled ECG Analysis Improves Diagnostic Accuracy and Reduces False STEMI Activations: A Multicenter U.S. Registry. JACC. Cardiovascular interventions 2026. link 20 Tsigkas G, Trigka-Vasilakopoulou A, Apostolos A, Papafaklis M, Colletti G, Mugnolo A et al.. Distal versus conventional transradial artery access for coronary catheterization in patients with STEMI (DR-STEMI): Rationale and design of an international, multicenter, randomized trial. American heart journal 2026. link 21 Miles Z, Thornton J. Seconds Matter: Novel Transport Solutions in Urban Settings Reduce Transport Times. The Journal of emergency medicine 2026. link 22 Veasaw K, Sharma P, Frishman WH, Aronow WS. Zalunfiban: A Review of Current Knowledge and Future Applications of an Innovative Antiplatelet Agent. Cardiology in review 2026. link 23 Armstrong PW, Zheng Y, Welsh RC, Sinnaeve PR, Van de Werf F, Westerhout CM et al.. Primary percutaneous coronary intervention within the first hour: Insights from early-treated patients with ST-elevation myocardial infarction. American heart journal 2026. link 24 Ting MJ, Hsieh CC, Yang HY, Jaw FS, Chen PC. Integration of Nitrogen Oxides Into a Triage-Based Index for Predicting Adverse Outcomes in ST-Segment Elevation Myocardial Infarction Patients. The Journal of emergency medicine 2026. link 25 Arabi A, Habib MB, Abdelghani MS, AlAmeen O, Al-Hijji M, Alqahtani A et al.. Association of pre-hospital shock team implementation with outcomes in ST-segment elevation myocardial infarction patients. Current problems in cardiology 2026. link 26 Reinstadler SJ, Kronbichler A, Reindl M, Tiller C, Holzknecht M, Oberhollenzer F et al.. Selective C-reactive protein apheresis in ST-elevation myocardial infarction: Design and rationale of the randomized CRP-STEMI trial. American heart journal 2026. link 27 Li T, Jin Y, Fu X. Does government purchase commitment promote regular production to emergency co-production? Differential game analysis on manufacturers' production strategy. Frontiers in public health 2025. link 28 Hou S, Liu L, Yao J, Zhao Q, Feng W, Liu Q et al.. Impact of exercise-based cardiac rehabilitation on cardiopulmonary function and prognosis in ST elevation myocardial infarction after PCI patients in extremely cold regions. BMC cardiovascular disorders 2025. link 29 Takamizawa K, Gohbara M, Hanajima Y, Tsutsumi K, Kirigaya H, Kirigaya J et al.. Long-term outcomes and operators' experience in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Cardiovascular intervention and therapeutics 2025. link 30 Carulli E, McGarvey M, Chabok M, Panoulas V, Rosser G, Akhtar M et al.. Transcoronary cooling and dilution for cardioprotection during revascularisation for ST-segment elevation myocardial infarction: Design and rationale of the STEMI-Cool study. American heart journal 2025. link 31 Laborante R, Paglianiti DA, Galli M, Patti G, D'Amario D. Impact of Mild Hypothermia As Adjunctive Therapy in Patients With ST-Elevation Myocardial Infarction: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2025. link 32 Krittanawong C, Ang SP, Maitra NS, Wang Z, Alam M, Jneid H et al.. Intravascular Imaging-Guided Versus Angiography-Guided Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction in the United States. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2025. link 33 Inan D, Genc D, Şimsek B, Tanık O, Akdeniz E, Korkmaz B et al.. Relationship Between CHA₂DS₂-VASc Score on Admission and In-Hospital Major Adverse Cardiovascular Events in Patients Diagnosed With ST-Elevation Myocardial Infarction. Angiology 2025. link 34 Park DY, Hu JR, Frampton J, Rymer J, Al Damluji A, Nanna MG. Complete revascularization versus culprit-only revascularization in older adults with ST-elevation myocardial infarction: Systematic review and meta-analysis of randomized controlled trials. Journal of the American Geriatrics Society 2025. link 35 Maqsood MH, Tamis-Holland JE, Feit F, Bangalore S. Revisiting the Efficacy and Safety of Bivalirudin in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2025. link 36 Garin D, Mendola E, Faucherre Y, Bennar W, Pittet T, Cook ST et al.. Disparities in ST-elevation myocardial infarction diagnosis and management among patients with mental health conditions. European heart journal. Quality of care & clinical outcomes 2025. link 37 Nikpay S, Leeberg M, Kozhimannil K, Ward M, Wolfson J, Graves J et al.. A proposed method for identifying Interfacility transfers in Medicare claims data. Health services research 2025. link 38 Doudkani Fard M, Separham A, Mamaghanizadeh E, Faridvand Y, Toupchi Khosroshahi V, Sarvari S. The association of the basal TIMI flow, post-PCI TIMI flow and thrombus grade with HbA1c levels in non-diabetic patients with acute ST segment elevation myocardial infarction undergoing primary PCI. Hormone molecular biology and clinical investigation 2025. link 39 Mila R, Albistur J, Valdez M, Loza G, Torrado J, Bachini J et al.. "A stratified pathway to stent-free reperfusion: Selecting suitable patients in ST-elevation myocardial infarction". Cardiovascular revascularization medicine : including molecular interventions 2025. link 40 Abdelwahab SI, Taha MME, Farasani A, Jerah AA, Abdullah SM, Oraibi B et al.. Bibliometric analysis of ST elevation myocardial infarction research from 1933 to 2023: Focus on top 100 most-cited articles. Current problems in cardiology 2025. link 41 Ruzzarin A, Muraglia S, Fabris E, Caretta G, Zilio F, Pezzato A et al.. Impact of Contrast-Associated Acute Kidney Injury on One-Year Outcomes in Very Elderly STEMI Patients: Insights From a Multicenter Registry in Northern Italy. Angiology 2025. link 42 The Nguyen Q, Van Nguyen T, Viet Phuong Nguyen T, Minh Tran H, Ngoc Dang S, Ngoc Hoan Nguyen B et al.. Frailty as an independent predictor for midterm adverse outcomes in the elderly undergoing primary percutaneous coronary intervention: A longitudinal cohort study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2025. link 43 Raillon LA, Bochaton T, Glorieux G, Guebre-Egziabher F, Soulage CO. The Uremic Toxin p-Cresyl Sulfate Is a New Predictor of Major Adverse Cardiovascular Events in Patients with ST-Elevation Myocardial Infarction. Toxins 2025. link 44 Xu J, Luo D, Lei Y, Hu Z, Tian H, Chen X et al.. Correlation between abnormal microvascular perfusion and quantitative flow ratio after primary PCI in patients with STEMI. International journal of cardiology 2025. link 45 Sawano M, Kohsaka S, Murugiah K, Ishii H, Yamaji K, Takahashi J et al.. Association of door-to-balloon time and one-year outcomes in hospital survivors of ST-elevation myocardial infarction. Journal of cardiology 2025. link 46 Kaddoura R, Mohamed Ibrahim MI, Arabi AR. Has low-dose intracoronary thrombolysis gained ground in primary percutaneous intervention?. Angiology 2025. link 47 Berry R, Harmouch KM, Roto A, Kumar N, Khan Z, Khanal R et al.. Morphine and P2Y12 Inhibitors in ST-Elevation Myocardial Infarction: An Updated Meta-Analysis. American journal of cardiovascular drugs : drugs, devices, and other interventions 2025. link 48 De Luca G, Algowhary M, Uguz B, Oliveira DC, Ganyukov V, Zimbakov Z et al.. Impact of diabetes on epicardial reperfusion and mortality in a contemporary STEMI population undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry. Nutrition, metabolism, and cardiovascular diseases : NMCD 2025. link 49 Schoenfeld D, Ho KKL, McCartin MP, Fritz C, Petcu R, Cohen J et al.. Longitudinal Assessment of a Single Referring-Receiving Hospital Pair to Assess Air Versus Ground Elapsed Time From Transport Request to Arrival at Cardiac Catheterization Laboratory: An Observational Cohort Study. Air medical journal 2025. link 50 Yılmaz C, Güvendi Şengör B, Karaduman A, Tiryaki MM, Kültürsay B, Unkun T et al.. Association of wide pulse pressure with coronary collateral flow in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention. Journal of human hypertension 2025. link 51 Kamaraj S, Firdaus ML, Norfarahdina R, Muizz AMA, Ranga ARA, Henry TD et al.. Clinical Outcomes and Practicality of Transferring Patients Immediately to Originating Hospitals After Primary Percutaneous Coronary Intervention-A Retrospective Study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2025. link 52 Jin Y, Lin Q, Wang D, Gong M, Huang W, Shan P et al.. Hypomagnesemia is a Risk Factor for Acute Kidney Injury in Patients Admitted With ST-Segment Elevation Myocardial Infarction: A Retrospective Observational Study. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2025. link 53 Akdeniz E, Hünük B, Yıldız C, Abdullahoğlu SD, Ortakaya M, Karabulut D et al.. ACEF score as a predictor of new-onset atrial fibrillation in patients with ST-elevation myocardial infarction: A retrospective cohort study. PloS one 2025. link 54 Yang N, Zhao W, Hao Y, Liu J, Liu J, Zhao X et al.. Incidence and risk factors for cardiac rupture after ST-segment elevation myocardial infarction in contemporary era: findings from the improving care for cardiovascular disease in China-Acute Coronary Syndrome project. Internal and emergency medicine 2025. link 55 De Luca G, Nardin M, Algowhary M, Uguz B, Oliveira DC, Ganyukov V et al.. Impact of hypertension on mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty: insights from the international multicenter ISACS-STEMI registry. Journal of hypertension 2025. link 56 Colaiori I, Biondi-Zoccai G, Spadafora L, Bernardi M, Aloia A, Ancona M et al.. Regional disparities in the management and outcomes of ST-elevation myocardial infarction: an Italian analysis focusing on time-dependent reperfusion networks and in-hospital logistics. Panminerva medica 2025. link 57 Cartanya-Bonvehi J, Pericas-Vila A, Subirana I, García-García C, Tizón-Marcos H, Elosua R. Effectiveness of STEMI networks with out-of-hospital triage: a systematic review and meta-analysis. Revista espanola de cardiologia (English ed.) 2025. link 58 Chen Y, Jiang M, Xia C, Zhao H, Ke P, Chen S et al.. A novel deep learning system for STEMI prognostic prediction from multi-sequence cardiac magnetic resonance. Science bulletin 2025. link 59 Liu H, Zhang F, Li Y, Liu L, Song X, Wang J et al.. The HALP score predicts no-reflow phenomenon and long-term prognosis in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. Coronary artery disease 2025. link 60 Mo DG, Wang MM. HbA1c/C-Peptide Ratio Is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction. Angiology 2025. link 61 Vacha J, Spacek M, Kaminek M, Hutyra M, Nykl R, Sluka M et al.. Comparison of myocardial perfusion study and invasive hemodynamic measurement of the significance of non-infarct-related residual stenoses in ST elevation myocardial infarction patients. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2025. link 62 Almeida EC, Albuquerque FN, Ferreira E, Pozzan R, Spineti PPM, Monteiro PS et al.. Geographic Variation in Door-to-Needle Time among Patients with STEMI from the Metropolitan Region of Rio de Janeiro: Results of the EQUITY-MI Cohort. Arquivos brasileiros de cardiologia 2025. link 63 Gatti M, Gallone G, D'Angelo T, Torlasco C, Andreis A, Castelletti S et al.. Rationale and design of the CT-STEMI study (Cardiac Computed Tomography for comprehensive risk stratification of arrhythmic, atherothrombotic and heart failure events following reperfused ST-segment Elevation Myocardial Infarction). Journal of cardiovascular computed tomography 2025. link 64 Weight N, Moledina S, Sun L, Kragholm K, Freeman P, Diaz-Arocutipa C et al.. Ethnic Disparities in ST-Segment Elevation Myocardial Infarction Outcomes and Processes of Care in Patients With and Without Standard Modifiable Cardiovascular Risk Factors: A Nationwide Cohort Study. Angiology 2024. link 65 Yarlioglues M, Karacali K, Ilhan BC, Yalcinkaya Oner D. A retrospective study: Association of C-reactive protein and uric acid to albumin ratio with the no-reflow phenomenon in patients with ST elevation myocardial infarction. International journal of cardiology 2024. link 66 Chen L, Sang C, Wu Y, Chen W, Ren Y, Che W et al.. Coronary Angiography-Derived Index of Microcirculatory Resistance Associated With New-Onset Atrial Fibrillation in Patients With STEMI. The Canadian journal of cardiology 2024. link 67 Konoma S, Sakakura K, Jinnouchi H, Taniguchi Y, Tsukui T, Hatori M et al.. Impact of the Japanese Version of High Bleeding Risk Criteria on Clinical Outcomes in Patients with ST-segment Elevation Myocardial Infarction. Journal of atherosclerosis and thrombosis 2024. link 68 Şaylık F, Çınar T, Selçuk M, Akbulut T, Hayıroğlu Mİ, Tanboğa İH. Evaluation of Naples Score for Long-Term Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Angiology 2024. link 69 Cordero A, Cid-Alvarez B, Monteiro P, García-Acuña JM, Gonçalves F, Escribano D et al.. Applicability of the Zwolle score for selection of very high-risk ST-elevation myocardial infarction patients treated with primary angioplasty. Angiology 2024. link 70 Corna G, Golino M, Talasaz AH, Moroni F, Del Buono MG, Damonte JI et al.. Response to interleukin-1 blockade with anakinra in women and men with ST-segment elevation myocardial infarction. Minerva cardiology and angiology 2024. link 71 Murakami T, Sakakura K, Jinnouchi H, Taniguchi Y, Tsukui T, Hatori M et al.. Development of a simple prediction model for mechanical complication in ST-segment elevation myocardial infarction patients after primary percutaneous coronary intervention. Heart and vessels 2024. link 72 Luan S, Zhang L, Cheng X, Wang Y, Feng Q, Wei L et al.. The ability and optimal cutoff value of serum cell division cycle 42 in estimating major adverse cardiac event in STEMI patients treated with percutaneous coronary intervention. Heart and vessels 2024. link 73 Sirén M, Leivo J, Anttonen E, Jolly SS, Dzavik V, Koivumäki J et al.. The prognostic significance of single-lead ST-segment resolution in ST-segment elevation myocardial infarction patients treated with primary PCI - A substudy of the randomized TOTAL trial. American heart journal 2024. link 74 Şaylık F, Çınar T, Sarıkaya R, Tanboğa İH. Development and Validation of Nomogram Based on the Systemic-Immune Inflammation Response Index for Predicting Contrast-Induced Nephropathy in ST-Elevation Myocardial Infarction Patients. Angiology 2024. link 75 Lin S, Shermeyer A, Nikpay S, Hsia RY, Ward MJ. Initial treatment of uninsured patients with ST-elevation myocardial infarction by facility percutaneous coronary intervention capabilities. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2024. link 76 Aydınyılmaz F, Özbeyaz NB, Guliyev İ, Algül E, Şahan HF, Kalkan K. Effect of Atherogenic Index of Plasma on Pre-Percutaneous Coronary Intervention Thrombolysis in Myocardial Infarction Flow in Patients With ST Elevation Myocardial Infarction. Angiology 2024. link 77 Wang C, Wang L, Yin J, Xuan H, Chen J, Li D et al.. Direct comparison of coronary microvascular obstruction evaluation using CMR feature tracking and layer-specific speckle tracking echocardiography in STEMI patients. The international journal of cardiovascular imaging 2024. link 78 Moroni F, Corna G, Del Buono MG, Golino M, Talasaz AH, Decotto S et al.. Impact of C-reactive protein levels and role of anakinra in patients with ST-elevation myocardial infarction. International journal of cardiology 2024. link 79 Şen F, Kurtul A, Bekler Ö. Pan-Immune-Inflammation Value Is Independently Correlated to Impaired Coronary Flow After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction. The American journal of cardiology 2024. link 80 Kobayashi S, Sakakura K, Jinnouchi H, Taniguchi Y, Tsukui T, Hatori M et al.. Impact of controlled blood pressure and pulse rate at discharge on clinical outcomes in patients with ST-segment elevation myocardial infarction. Journal of cardiology 2024. link 81 Chou YH, Huang CC, Chang CK, Huang JL, Jang BH, Lee TH et al.. The Coronary Reperfusion Effect and Safety of Prehospital P2Y12 Inhibitor in Primary-PCI STEMI Patients: A Systematic Review and Meta-Analysis. Prehospital emergency care 2024. link 82 Barrionuevo-Sánchez MI, Ariza-Solé A, Viana-Tejedor A, Del Prado N, Rosillo N, Jorge-Pérez P et al.. Clinical profile, management and outcomes of patients with cardiogenic shock undergoing transfer between centers in Spain. Revista espanola de cardiologia (English ed.) 2024. link 83 Ji H, Chen S, Hu Q, He Y, Zhou L, Xie J et al.. Investigating the Correlation between Serum Amyloid A and Infarct-Related Artery Patency Prior to Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients. Angiology 2024. link 84 Liu W, Li Z, Yang T, A G, Sun H, Liu H et al.. Association Between Platelet Glycoprotein IIb/IIIa Inhibition and In-Hospital Outcomes in ST-Elevation Myocardial Infarction Patients Treated with Coronary Thrombus Aspiration: Findings from the CCC-ACS Project. Cardiovascular drugs and therapy 2024. link 85 Rodríguez-Ramos MA, Santos-Medina M, Dueñas-Herrera A, Prohías Martínez JA, Rivas-Estany E. A collaborative approach to develop indicators for quality of care for ST segment Elevation Myocardial Infarction in networks without coronary intervention: A position paper. The International journal of risk & safety in medicine 2024. link 86 Carreras-Mora J, Vidal-Burdeus M, Rodríguez-González C, Simón-Ramón C, Rodríguez-Sotelo L, Sionis A et al.. Killip scale reclassification according to lung ultrasound: Killip pLUS. European heart journal. Acute cardiovascular care 2024. link 87 Miyake M, Izumi C, Watanabe H, Ozasa N, Morimoto T, Matsutani H et al.. Prognostic value of E/e' ratio and its change over time in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction in the reperfusion era. Journal of cardiology 2024. link 88 Wu H, Wang H, Wang X, Xu L, Wu J. Myocardial strain combined with clinical risk factors in the prediction of in-hospital heart failure among patients with ST-segment elevation myocardial infarction. Clinical radiology 2024. link 89 Ashraf S, Farooq U, Shahbaz A, Khalique F, Ashraf M, Akmal R et al.. Factors Responsible for Worse Outcomes in STEMI Patients With Early vs Delayed Treatment Presenting in a Tertiary Care Center in a Third World Country. Current problems in cardiology 2024. link 90 Archilletti F, Ricci F, Pelliccia F, Dangas G, Giuliani L, Radico F et al.. Coronary angiography- or fractional flow reserve-guided complete revascularization in multivessel disease STEMI: A Bayesian hierarchical network meta-analysis. International journal of cardiology 2023. link 91 Ludman P, Zeymer U, Danchin N, Kala P, Laroche C, Sadeghi M et al.. Care of patients with ST-elevation myocardial infarction: an international analysis of quality indicators in the acute coronary syndrome STEMI Registry of the EURObservational Research Programme and ACVC and EAPCI Associations of the European Society of Cardiology in 11 462 patients. European heart journal. Acute cardiovascular care 2023. link 92 Aly S, Coolahan K, Tomlinson K, Grossman D, Bove J, Hochman S. Does Inclusion of Emergency Medicine (EM) Residents in ECG Screening for STEMI Change the Time to Catheterization Lab Activation?. Critical pathways in cardiology 2023. link 93 Delewi R, Vogel RF, Wilschut JM, Lemmert ME, Diletti R, van Vliet R et al.. Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction. American heart journal 2023. link 94 Roohafza H, Noohi F, Hosseini SG, Alemzadeh-Ansari M, Bagherieh S, Marateb H et al.. A Cardiovascular Risk Assessment Model According to Behavioral, Psychosocial and Traditional Factors in Patients With ST-Segment Elevation Myocardial Infarction (CRAS-MI): Review of Literature and Methodology of a Multi-Center Cohort Study. Current problems in cardiology 2023. link 95 Rao K, Danaila V, Bennett RG, Turnbull S, Campbell T, Kumar S. Correlation of exit sites of inducible ventricular tachycardia post-ST elevation myocardial infarction on electrophysiology study, with region of infarct. Internal medicine journal 2023. link 96 Dang D, Dowling C, Zaman S, Cameron J, Kuhn L. Predictors of radial to femoral artery crossover during primary percutaneous coronary intervention in ST-elevation myocardial infarction: A systematic review and meta-analysis. Australian critical care : official journal of the Confederation of Australian Critical Care Nurses 2023. link 97 Çınar T, Şaylık F, Akbulut T, Korkmaz Y, Çiçek V, Asal S et al.. Evaluation of Intermountain Risk Score for Short- and Long-Term Mortality in ST Elevation Myocardial Infarction Patients. Angiology 2023. link 98 Jha A, Ojha CP, Bhattad PB, Sharma A, Thota A, Mishra AK et al.. ST elevation myocardial infarction - national trend analysis with mortality differences in outcomes based on day of hospitalization. Coronary artery disease 2023. link 99 Goel A, Malik AH, Bandyopadhyay D, Isath A, Gupta R, Hajra A et al.. Impact of COVID-19 on Outcomes of Patients Hospitalized With STEMI: A Nationwide Propensity-matched Analysis. Current problems in cardiology 2023. link 100 Liu Y, Kang S, Li X, Liu Z, Gao Y, Wang X. Modified ticagrelor loading doses according to the vasodilator-stimulated phosphoprotein phosphorylation index improve the clinical outcome in ST-elevation myocardial infarction patients with high on-treatment platelet reactivity. Cardiology journal 2023. link